Compare stocks

ChemoMetec A/S is a biotechnology and life sciences company that specializes in the development, production, and sale of high-quality instruments for cell counting and analysis. Located in Denmark, the company serves various sectors, including research institutions, academic laboratories, and pharmaceutical companies. Its product portfolio includes advanced cell counters and analyzers, such as the NucleoCounter series, which are utilized for precise and reliable cell counting across multiple applications. Established in 1997, ChemoMetec has positioned itself through innovative technology that focuses on accuracy and ease of use. The company operates with a global reach, serving customers through both direct sales and a network of distributors.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.